Sinopharm is developed by the Beijing Institute of Biological Products, a state-owned subsidiary conglomerate.(Reuters)
Sinopharm is developed by the Beijing Institute of Biological Products, a state-owned subsidiary conglomerate.(Reuters)

WHO says expects news on Friday on Sinopharm vaccine emergency use listing

  • "We are kind of expecting an update on the EUL listing for Sinopharm in the next hour or so," WHO spokesman Christian Lindmeier told a UN briefing.
Reuters |
PUBLISHED ON MAY 07, 2021 03:57 PM IST

The World Health Organization (WHO) expects news on Friday regarding an emergency use listing for the COVID-19 vaccine made by Chinese state-owned drugmaker Sinopharm, a WHO spokesman said.

"We are kind of expecting an update on the EUL listing for Sinopharm in the next hour or so," WHO spokesman Christian Lindmeier told a UN briefing. Results of its review of the COVID-19 shot made by Sinovac Biotech could come next week, he said.

A WHO emergency listing is a signal to national regulators on a product's safety and efficacy. It would also allow the shot to be included in COVAX, the global programme to provide vaccines mainly for poor countries, but which currently faces major supply constraints.


SHARE THIS ARTICLE ON
Close
SHARE
Story Saved
OPEN APP